3 Wholesale Stocks Pushing The Industry Higher
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.
All three major indices are trading up today with the
Dow Jones Industrial Average
(
^DJI
) trading up 53 points (0.3%) at 17,715 as of Wednesday, March 11, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,670 issues advancing vs. 1,290 declining with 158 unchanged.
The Wholesale industry currently sits up 0.3% versus the S&P 500, which is up 0.2%. A company within the industry that increased today was
(
), up 1.2%.
TheStreet would like to highlight 3 stocks pushing the industry higher today:
3.
(
) is one of the companies pushing the Wholesale industry higher today. As of noon trading, Cardinal Health is up $0.46 (0.5%) to $87.40 on light volume. Thus far, 540,716 shares of Cardinal Health exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $86.50-$87.52 after having opened the day at $87.11 as compared to the previous trading day's close of $86.94.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. Cardinal Health has a market cap of $29.0 billion and is part of the services sector. Shares are up 7.7% year-to-date as of the close of trading on Tuesday. Currently there are 12 analysts who rate Cardinal Health a buy, no analysts rate it a sell, and 3 rate it a hold.
TheStreet Ratings rates
Cardinal Health
as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full
Cardinal Health Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
2. As of noon trading,
(
) is up $0.74 (0.7%) to $103.67 on light volume. Thus far, 508,062 shares of AmerisourceBergen exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $102.95-$103.89 after having opened the day at $103.40 as compared to the previous trading day's close of $102.93.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. AmerisourceBergen has a market cap of $22.7 billion and is part of the services sector. Shares are up 14.2% year-to-date as of the close of trading on Tuesday. Currently there are 6 analysts who rate AmerisourceBergen a buy, no analysts rate it a sell, and 8 rate it a hold.
TheStreet Ratings rates
AmerisourceBergen
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full
AmerisourceBergen Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
1. As of noon trading,
(
) is up $1.55 (0.7%) to $222.40 on light volume. Thus far, 268,777 shares of McKesson exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $220.74-$222.98 after having opened the day at $221.45 as compared to the previous trading day's close of $220.85.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
McKesson Corporation delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. McKesson has a market cap of $52.5 billion and is part of the services sector. Shares are up 6.4% year-to-date as of the close of trading on Tuesday. Currently there are 14 analysts who rate McKesson a buy, no analysts rate it a sell, and 1 rates it a hold.
TheStreet Ratings rates
McKesson
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, good cash flow from operations, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the wholesale industry could consider
iShares Dow Jones US Cons Goods
(
) while those bearish on the wholesale industry could consider
ProShares Ultra Sht Consumer Goods
(
).
null